Conference Coverage

PSYCHIATRY UPDATE 2016


 

Innovative Treatments of Anxiety, Part 1 (Use of Benzodiazepines)
Mark H. Pollack, MD, Rush University Medical Center

Benzodiazepines are effective, well-tolerated, have a rapid onset of action, and can be used as needed for situational anxiety, although they are associated with sedation, psychomotor impairment, physical dependence, and adverse interactions with alcohol. All benzodiazepines are effective for generalized anxiety disorder, but for maintenance treatment, consider a longer-acting agent. Consider combining benzodiazepines with antidepressants for rapid relief of anxiety while antidepressants begin to work, to treat residual anxiety, or to decrease early anxiety associated with antidepressant treatment. Reported increase in overdose mortality likely is conflation with other drugs of abuse, particularly opioids. Dr. Pollack ended his presentation by reviewing the use of tricyclic antidepressants, monoamine oxidase inhibitors, and other antidepressants for anxiety disorders.

Pages

Recommended Reading

FDA announces new plan to combat opioid abuse
MDedge Psychiatry
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Psychiatry
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Psychiatry
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Psychiatry
Opioid prescribing: An odyssey of challenges
MDedge Psychiatry
Opiate drug detox appears safe in pregnancy
MDedge Psychiatry
Pot tied to increased risk of substance use disorders, not depression or anxiety
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Marijuana tourists also visiting Colorado EDs
MDedge Psychiatry
VIDEO: How proposed patient substance use privacy rule impacts physicians
MDedge Psychiatry